Sodium hydroxide

500

BP, ChP, JP, NF, Ph. Eur.

>1 (vs air)

<18 mmHg ( 20 °C), 3 mmHg ( 37 °C)

suitable for the biopharmaceutical production

EMPROVE^® EXPERT

≥98.0-100.5% (total alkilinity calculated as NaOH)

pellets, solid

>14 (20 °C, 100 g/L in H₂O)

318 °C (lit.)

water: 1090 g/L at 20 °C

2.13 g/cm³ at 20 °C

carbonate (as Na₂CO₃): ≤0.5%, chloride (Cl^-): ≤0.015%, phosphate (PO₄^3-): ≤0.001%, silicate (as SiO₂): ≤0.01%, sulfate (SO₄^2-): ≤0.010%

Al: ≤0.001%, As: ≤0.0003%, Ca: ≤0.005%, Cu: ≤0.0005%, Fe: ≤0.0010%, Hg: ≤0.00001%, K: ≤0.05%, Mg: ≤0.002%, Ni: ≤0.001%, Pb: ≤0.00005%, Zn: ≤0.0025%, heavy metals (as Ag): ≤0.002%, heavy metals (as Pb): ≤0.0005%

liquid formulation
parenterals
pharma/biopharma processes
pharmaceutical

15-25°C

[OH-].[Na+]

1S/Na.H2O/h;1H2/q+1;/p-1

HEMHJVSKTPXQMS-UHFFFAOYSA-M